O
TEVA icon

OppenheimerFunds’s Teva Pharmaceuticals TEVA Stock Holding History

OppenheimerFunds’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,233,132
Closed -$91.2M – 1860
2018
Q3 		$91.2M Sell
4,233,132
-1,321
-0% -$30.7K 0.11% 216
2018
Q2 		$103M Buy
4,234,453
+4,945
+0.1% +$101K 0.12% 187
2018
Q1 		$72.3M Buy
4,229,508
+566,300
+15% +$11.1M 0.09% 243
2017
Q4 		$69.4M Buy
+3,663,208
New +$55.1M 0.08% 247
2017
Q3 		– Sell
-521,869
Closed -$17.3M – 1871
2017
Q2 		$17.3M Sell
521,869
-142,701
-21% -$4.42M 0.02% 597
2017
Q1 		$21.3M Sell
664,570
-899,405
-58% -$30.7M 0.03% 561
2016
Q4 		$56.7M Sell
1,563,975
-328,400
-17% -$13.1M 0.07% 283
2016
Q3 		$87.1M Sell
1,892,375
-143,185
-7% -$7.47M 0.11% 220
2016
Q2 		$102M Sell
2,035,560
-116,605
-5% -$6.21M 0.13% 187
2016
Q1 		$115M Sell
2,152,165
-532,760
-20% -$31.3M 0.15% 163
2015
Q4 		$176M Sell
2,684,925
-245,716
-8% -$15.2M 0.22% 112
2015
Q3 		$165M Buy
2,930,641
+678,370
+30% +$44M 0.22% 118
2015
Q2 		$133M Sell
2,252,271
-50,384
-2% -$3.11M 0.15% 170
2015
Q1 		$143M Buy
2,302,655
+1,159,690
+101% +$67.4M 0.16% 167
2014
Q4 		$65.7M Sell
1,142,965
-316,524
-22% -$17.6M 0.07% 291
2014
Q3 		$78.4M Sell
1,459,489
-232,791
-14% -$12.3M 0.09% 243
2014
Q2 		$88.7M Sell
1,692,280
-22,755
-1% -$1.16M 0.1% 226
2014
Q1 		$90.6M Sell
1,715,035
-143,816
-8% -$6.65M 0.11% 220
2013
Q4 		$74.5M Sell
1,858,851
-2,679,569
-59% -$106M 0.09% 247
2013
Q3 		$171M Buy
4,538,420
+2,458,190
+118% +$95.9M 0.11% 224
2013
Q2 		$81.5M Buy
+2,080,230
New +$81M 0.12% 221

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

OppenheimerFunds's TEVA Position: Q4 2018 in Review

OppenheimerFunds sold out of Teva Pharmaceuticals (TEVA) in Q4 2018, closing a stake of 4,233,132 shares — an estimated $91.2M sold.

OppenheimerFunds first reported a position in TEVA in Q2 2013 and held it in 21 quarters. The position peaked at $176M in Q4 2015. 552 funds tracked by Wall St. Rank hold TEVA as of Q4 2018.

  • OppenheimerFunds reported no remaining Teva Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • OppenheimerFunds sold 4,233,132 Teva Pharmaceuticals shares in Q4 2018, an estimated $91.2M.
  • OppenheimerFunds first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 21 quarters.
  • OppenheimerFunds's Teva Pharmaceuticals position peaked at $176M in Q4 2015.
  • 552 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2018.

Based on OppenheimerFunds's 13F filing for Q4 2018, filed 11 Feb 2019.